Rabies
Conditions
Interventions
Injection of Ormutivima in rabies-exposed patients:NA
Sponsors
Peking University First Hospital
Eligibility
Sex/Gender
All
Age
2 Years to No maximum
Inclusion criteria
Inclusion criteria: 1) Rabies virus exposed persons aged 2 years or older at enrollment. 2) The subjects were treated with Ormutivima during PEP and had completed PEP for >=7 days and within 90 days after administration. 3) Subjects or their legal guardians expressed informed consent through telephone. They were able and willing to comply with the requirements of the study protocol and cooperate with the study arrangements.
Exclusion criteria
Exclusion criteria: 1) Participate enroll in other drug or vaccine clinical trials during the planned study period. 2) The investigator believes that the subject is in any condition that may interfere with the assessment of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Body temperature; | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse reactions; | — |
Countries
China
Contacts
Public ContactCheng Liu
Peking University First Hospital
Outcome results
None listed